A 42-year-old man from Mumbai with a 2-year history of recurrent epigastric pain and nausea undergoes upper endoscopy, which reveals a 1.5 cm antral ulcer with surrounding erythema and oedema. Rapid urease test on antral biopsy is positive within 10 minutes. Serum IgG antibodies against the organism are also positive. Histology shows curved, gram-negative bacilli in the mucus layer adjacent to the gastric epithelium. The patient has no alarm features (no weight loss, no vomiting, no anaemia). What is the most appropriate next step in management?

Explanation

## Helicobacter pylori Infection & Management ### Diagnosis Confirmation **Key Point:** The rapid urease test (RUT) positivity within 10 minutes is diagnostic for *Helicobacter pylori*. The organism produces urease, which cleaves urea to ammonia and CO~2~, raising local pH and allowing survival in the acidic stomach. | Diagnostic Test | Sensitivity | Specificity | Timing | Notes | |-----------------|-------------|------------|--------|-------| | **Rapid urease test (RUT)** | 85–95% | 95–98% | 10–30 min | Requires biopsy; endoscopy-dependent | | **Histology** | 90–95% | 99% | 2–3 days | Gold standard; allows visualization | | **Serology (IgG)** | 90–95% | 90–95% | Same day | Indicates current or past infection | | **Stool antigen** | 85–95% | 90–95% | 1–2 days | Non-invasive; good for follow-up | | **Urea breath test (UBT)** | 95–98% | 95–98% | 20–30 min | Non-invasive; gold standard for eradication | **Clinical Pearl:** Serum IgG positivity indicates either current infection or past exposure; it does NOT distinguish active from resolved infection. RUT and histology confirm active infection. ### Indications for H. pylori Eradication **High-Yield:** NEET PG emphasizes that **all patients with documented *H. pylori* infection and peptic ulcer disease MUST be treated**, regardless of symptoms. **Mnemonic: PUMP** — **P**eptic ulcer, **U**ndiagnosed dyspepsia, **M**ALT lymphoma, **P**revention (in high-risk populations). 1. **Peptic ulcer disease** (duodenal or gastric) — **MUST treat** 2. **MALT lymphoma** (gastric) 3. **Chronic gastritis with atrophy or intestinal metaplasia** 4. **Dyspepsia** (uninvestigated or investigated) 5. **First-degree relatives of gastric cancer patients** (in high-incidence regions like East Asia, India) 6. **Patients on long-term NSAIDs or low-dose aspirin** ### Standard Triple Therapy (First-Line) **Key Point:** The **gold standard** for *H. pylori* eradication is **proton pump inhibitor (PPI) + two antibiotics** for **14 days**. ```mermaid flowchart TD A["H. pylori infection confirmed"]:::outcome --> B{"Eradication indicated?"}:::decision B -->|"Yes: PUD, MALT, etc."| C["Triple therapy x 14 days"]:::action C --> D["PPI: Omeprazole 20 mg BD<br/>or Pantoprazole 40 mg BD"]:::action D --> E["+ Amoxicillin 1 g BD<br/>+ Clarithromycin 500 mg BD"]:::action E --> F["Eradication achieved?"]:::decision F -->|"Yes (85–90% eradication)"| G["Continue PPI for 4–8 weeks<br/>for ulcer healing"]:::action F -->|"No: Failure"| H["Quadruple therapy or<br/>Levofloxacin-based regimen"]:::action G --> I["Confirm eradication<br/>UBT or stool antigen<br/>at 4 weeks post-treatment"]:::action ``` ### Standard Triple Therapy Regimen | Component | Dose | Duration | Notes | |-----------|------|----------|-------| | **Omeprazole** | 20 mg BD | 14 days | PPI; reduces acid, enhances antibiotic activity | | **Amoxicillin** | 1 g BD | 14 days | Beta-lactam; excellent gastric penetration | | **Clarithromycin** | 500 mg BD | 14 days | Macrolide; good H. pylori coverage | **High-Yield:** This regimen achieves **85–90% eradication** in most populations. Duration is **14 days** (not 7 or 10 days). ### Why Omeprazole Monotherapy Is Insufficient **Warning:** Omeprazole alone does **NOT** eradicate *H. pylori*. Although acid suppression may relieve symptoms temporarily, the organism persists in the mucus layer and will cause relapse. Monotherapy is **never appropriate** for confirmed infection with ulcer disease. ### Why Bismuth Monotherapy Is Insufficient **Warning:** Bismuth subsalicylate alone has poor eradication rates (~30–40%) and is not recommended as monotherapy. Bismuth is used **only as part of quadruple therapy** (PPI + bismuth + two antibiotics) in cases of triple-therapy failure or in regions with high clarithromycin resistance. ### Why Observation Without Treatment Is Inappropriate **Key Point:** **All patients with confirmed *H. pylori* infection and peptic ulcer disease MUST be treated.** Observation without eradication risks: - **Ulcer recurrence** (>90% relapse rate without treatment) - **Chronic gastritis progression** → intestinal metaplasia → gastric adenocarcinoma - **MALT lymphoma development** (rare but serious) **Clinical Pearl:** In India, where gastric cancer incidence is higher, eradication of *H. pylori* in patients with ulcer disease is particularly important. ### Post-Treatment Confirmation **High-Yield:** After completing eradication therapy: 1. **Wait ≥4 weeks** after treatment completion 2. **Confirm eradication** using: - **Urea breath test (UBT)** — non-invasive, gold standard - **Stool antigen test** — non-invasive, good sensitivity - **Repeat RUT/histology** — only if symptoms persist or UBT unavailable 3. **Do NOT use serology** — IgG remains positive for months/years after eradication ### Ulcer Healing After Eradication **Key Point:** After successful eradication, continue PPI for **4–8 weeks** to allow ulcer healing, even if symptoms resolve earlier. ## Why This Is High-Yield **High-Yield:** This question tests: - **Diagnosis of *H. pylori*** (RUT, serology, histology) - **Indications for eradication** (peptic ulcer disease is absolute) - **Standard triple therapy regimen** (PPI + 2 antibiotics × 14 days) - **Why monotherapy fails** (organism persists; relapse is inevitable) - **Post-treatment confirmation** (UBT, not serology) [cite:Harrison 21e Ch 297; Park 26e Ch 21]